Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: King's Invasive Aspergillosis Study II [Phase 4]
A Phase 4 clinical trial update for King's Invasive Aspergillosis Study II (NCT02875743) from King's College Hospital NHS Trust, with condit…
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: Study to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Dependent Participants With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Who Are Relapsed or Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment [Phase 2]
A Phase 2 study evaluating talacotuzumab or daratumumab in transfusion-dependent myelodysplastic syndrome patients relapsed or refractory to…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders [Phase 2]
Phase 2 trial update of an allogeneic hematopoietic cell transplant in hematologic cancers/disorders; status completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations [Phase 2, Phase 3]
A phase 2/3 trial evaluating the addition of one of two novel treatment agents to standard chemotherapy in acute myeloid leukemia and myelod…
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT [Phase 1]
Phase 1 trial exploring a calcineurin inhibitor-free graft-versus-host disease prevention regimen after related haploidentical peripheral bl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease [Phase 1]
Phase 1 trial evaluating lenalidomide after allogeneic hematopoietic cell transplant in AML and MDS patients with minimal residual disease; …
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS) [Phase 2]
Phase 2 trial investigating lirilumab and nivolumab with 5-azacitidine in myelodysplastic syndromes has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating chemotherapy, radiation therapy, and Umbilical Cord Blood Transplantation for hematologic cancers complete…
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia [Phase 2]
A Phase 2 trial evaluating doxercalciferol in patients with myelodysplastic syndromes or related leukemias has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial investigating mycophenolate mofetil, tacrolimus, daclizumab, and donor peripheral stem cell transplantation for hemat…
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 4]
Phase 4 clinical trial update on bone marrow transplantation for hematologic cancers, including conditions such as anemia and graft-versus-h…
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update on peripheral stem cell transplantation for hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers [Phase 2]
Phase 2 trial evaluating bevacizumab in combination with cytarabine and mitoxantrone for hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation [Phase 1, Phase 2]
Phase 1/2 clinical trial of azacitidine in patients undergoing matched unrelated donor stem cell transplantation has been terminated; result…
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 trial evaluating total-body irradiation with fludarabine and peripheral stem cell transplantation in patients with hematologic cance…
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 pilot study evaluating eltrombopag, a thrombopoietin-receptor agonist, in patients with low- to intermediate-2 risk myelodysplastic …
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) [Phase 1, Phase 2]
A clinical trial update for sapacitabine in acute myeloid leukemia and myelodysplastic syndromes (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2019-06-13Clinical Trial Update: Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML) [Phase 2]
Phase 2 study evaluating sotatercept for anemia in patients with low- or intermediate-1 risk myelodysplastic syndromes and non-proliferative…
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: A Study of Azacitidine for Patients With Int/High -Risk MDS and AML-MRC [Phase 3]
Phase 3 trial evaluating azacitidine in patients with intermediate/high-risk myelodysplastic syndromes and AML with myelodysplasia-related c…
-
CLINICAL_TRIALS trial_result · 2019-05-22Clinical Trial Update: Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating decitabine with total-body irradiation followed by donor bone marrow transplant and cyclophosphamide for relapsed o…
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders [Phase 2]
Phase 2 clinical trial evaluating post-infusion allogeneic cytokine-induced killer (CIK) cells as consolidative therapy in myelodysplastic s…
-
CLINICAL_TRIALS trial_result · 2019-05-06Clinical Trial Update: Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) [Phase 2]
Phase 2 trial evaluating dasatinib for myeloproliferative disorders; the study has completed and results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-14Clinical Trial Update: Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy [Phase 2]
A Phase 2 clinical trial evaluating safety of bone marrow transplant from mismatched tissue followed by chemotherapy in patients with myelod…
-
CLINICAL_TRIALS trial_result · 2019-03-07Clinical Trial Update: A Study of Galunisertib in Participants With Myelodysplastic Syndromes [Phase 2, Phase 3]
Phase 2/3 trial evaluating galunisertib in myelodysplastic syndromes has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies [Phase 2]
Phase 2 clinical trial updating the use of off-the-shelf expanded cord blood cells to augment cord blood transplant in patients with various…